These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3167234)

  • 1. Markers in breast cancer: does CEA add to the detection by CA 15.3?
    Delarue JC; Mouriesse H; Dubois F; Friedman S; May-Levin F
    Breast Cancer Res Treat; 1988 Jul; 11(3):273-6. PubMed ID: 3167234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The value of tumor markers CA 15-3 and CEA in breast cancer].
    Buck I; Lindner C; Böge K; Kitschke HJ
    Arch Gynecol Obstet; 1989; 245(1-4):674-7. PubMed ID: 2802753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating CA 15-3 levels in the postsurgical follow-up of breast cancer patients and in non-malignant diseases.
    Colomer R; Ruibal A; Genollá J; Rubio D; Del Campo JM; Bodi R; Salvador L
    Breast Cancer Res Treat; 1989 Mar; 13(2):123-33. PubMed ID: 2730960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison between pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG), carcino-embryonic antigen (CEA), CA-125, and CA-15-3 as tumor markers in breast cancer.
    Bersinger NA; Rageth JC
    Eur J Gynaecol Oncol; 1990; 11(2):135-9. PubMed ID: 2379513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic significance of the tumour markers CEA, CA 15-3 and CA 125 in malignant effusions in breast cancer.
    Kandylis K; Vassilomanolakis M; Baziotis N; Papadimitriou A; Tsoussis S; Ferderigou A; Efremidis AP
    Ann Oncol; 1990 Nov; 1(6):435-8. PubMed ID: 2083187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of mucin-like carcinoma-associated antigen (MCA) in breast cancer.
    Rasoul-Rockenschaub S; Zielinski CC; Kubista E; Vavra N; Pospischil E; Staffen A; Czerwenka K; Aiginger P; Spona J
    Eur J Cancer Clin Oncol; 1989 Jul; 25(7):1067-72. PubMed ID: 2759162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 50, and carbohydrate antigen 19-9 in the diagnosis of colorectal adenocarcinoma.
    Alvarez JA; Marín J; Jover JM; Fernández R; Fradejas J; Moreno M
    Dis Colon Rectum; 1995 May; 38(5):535-42. PubMed ID: 7537651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of serial carcinoembryonic antigen and CA 15.3 assays in detecting relapses in breast cancer patients.
    Molina R; Zanón G; Filella X; Moreno F; Jo J; Daniels M; Latre ML; Giménez N; Pahisa J; Velasco M
    Breast Cancer Res Treat; 1995; 36(1):41-8. PubMed ID: 7579505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour markers in colorectal cancer.
    Roberts PJ
    Scand J Gastroenterol Suppl; 1988; 149():50-8. PubMed ID: 3201159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tumor markers in breast cancer: on the diagnostic value of serum determinations in clinical freedom from tumor and manifest disease].
    Günczler P; Ogris E; Maca S; Danmayr E
    Onkologie; 1989 Oct; 12(5):209-14. PubMed ID: 2685686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic oncofetal antigen and carcinoembryonic antigen in breast and colon carcinoma.
    Kithier K; Samal B; Cejka J; Whitcomb MP; Mood DW
    Tumour Biol; 1988; 9(6):307-14. PubMed ID: 3206109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of CA 549 in pleural fluid. Comparison with CEA, CA 15.3 and CA 72.4.
    Villena V; López-Encuentra A; Echave-Sustaeta J; Martín-Escribano P; Ortuño-de-Solo B; Estenoz-Alfaro J
    Lung Cancer; 2003 Jun; 40(3):289-94. PubMed ID: 12781427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients.
    Nicolini A; Colombini C; Luciani L; Carpi A; Giuliani L
    Br J Cancer; 1991 Jul; 64(1):154-8. PubMed ID: 1854615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between tissue and serum content of CA 125, CA 19-9, and carcinoembryonic antigen in ovarian tumors.
    Breitenecker G; Neunteufel W; Bieglmayer C; Kölbl H; Schieder K
    Int J Gynecol Pathol; 1989; 8(2):97-102. PubMed ID: 2714933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoembryonic antigen and carbohydrate 19-9 antigen as markers for colorectal carcinoma in children and adolescents.
    Angel CA; Pratt CB; Rao BN; Schell MJ; Parham DM; Lobe TE; Fleming ID
    Cancer; 1992 Mar; 69(6):1487-91. PubMed ID: 1311626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [CA 15-3 in the diagnosis and monitoring of carcinoma of the breast and its correlations with CEA].
    Festa V; Alabiso O; Piantino P; Lisa F; Zanini M; Garrone C; Simone P; Morino M
    Minerva Chir; 1989 Mar; 44(6):1015-20. PubMed ID: 2733831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new biomarker in monitoring breast cancer: CA 549.
    Beveridge RA; Chan DW; Bruzek D; Damron D; Bray KR; Gaur PK; Ettinger DS; Rock RC; Shurbaji MS; Kuhajda FP
    J Clin Oncol; 1988 Dec; 6(12):1815-21. PubMed ID: 3058875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of tumour markers CA50, CEA and TPA in female breast carcinoma as related to histopathological findings and survival.
    Eskelinen M; Lipponen P; Syrjänen K
    Anticancer Res; 1992; 12(1):91-5. PubMed ID: 1567186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of a tumor marker NCC-ST-439 in breast cancer--a comparative study with CA 15-3, CEA and TPA].
    Okamura Y; Takatsuka Y; Katoh T; Tsumura I; Kobayakawa K; Kawahara T
    Gan To Kagaku Ryoho; 1991 Jul; 18(8):1279-85. PubMed ID: 2069399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of carcinoembryonic antigen, squamous cell carcinoma antigen, CA 125, and CA 50 cytosolic content in non-small cell lung cancer.
    Picardo AL; Torres AJ; Maestro M; Ortega D; Garcia-Asenjo JA; Mugüerza JM; Hernando F; Diez M; Balibrea JL
    Cancer; 1994 May; 73(9):2305-11. PubMed ID: 8168034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.